{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02985346",
      "OrgStudyIdInfo": {
        "OrgStudyId": "WTan"
      },
      "Organization": {
        "OrgFullName": "Sun Yat-sen University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis",
      "OfficialTitle": "Sun Yat-sen Memorial Hospital"
    },
    "StatusModule": {
      "StatusVerifiedDate": "December 2016",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "January 2017"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 3, 2016",
      "StudyFirstSubmitQCDate": "December 6, 2016",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "December 7, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "December 6, 2016",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "December 7, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Weiping Tan",
        "ResponsiblePartyInvestigatorTitle": "Sun Yat-sen Memorial Hospital",
        "ResponsiblePartyInvestigatorAffiliation": "Sun Yat-sen University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Sun Yat-sen University",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {},
    "DescriptionModule": {
      "BriefSummary": "Pulmonary hemosiderosis (PH) is a pulmonary hemosiderin deposition which caused by alveolar capillary hemorrhage. PH is easy to recurrent and can lead to pulmonary fibrosis and insufficiency if the disease was poor controlled. Steroid is the most common drug that was administered in acute phase of the disease. However, considered the side-effects, steroid is not suitable for long-time maintenance. Therefore, it is necessary to explore a new therapy. Bone marrow mesenchymal stem cells (BMSC) are a kind of adult stem cells with high self-renewal and multi-directional differentiation potential in bone marrow. It has become a hot topic in immunosuppressive and tissue repair therapy in recent years. To date, homing, colonization and differentiation of BMSCs in the lung have been observed in animal models of pulmonary hypertension, radiation pneumonitis and pulmonary fibrosis. It had been reported that BMSC transplantation in acute lung injury in mice, inflammation of lung injury can significantly improve. The aim of this study is to explore the effect of BMSC on PH and its mechanism, and to explore a new way to promote the repair of IPH. It is expected to improve the status of IPH therapy in children, especially improve the prognosis of refractory PH."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Idiopathic Pulmonary Hemosiderosis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Idiopathic pulmonary hemosiderosis",
          "Bone marrow mesenchymal stem cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Early Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "100",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "BMSC group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients received Bone marrow mesenchymal stem cells (BMSC) plus standard treatment",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control group",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Patients received standard treatment",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "BMSC group",
                "Control group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Complete remission",
            "PrimaryOutcomeTimeFrame": "3-6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients diagnosed with Pulmonary hemosiderosis at an age less than 18 years.\n\nExclusion Criteria:\n\nPatients who cannot finish the established causes or die during the causes.",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "All",
      "MinimumAge": "1 Month",
      "MaximumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult"
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "4800237",
            "ReferenceType": "background",
            "ReferenceCitation": "Byrd RB, Gracey DR. Immunosuppressive treatment of idiopathic pulmonary hemosiderosis. JAMA. 1973 Oct 22;226(4):458-9."
          },
          {
            "ReferencePMID": "11665500",
            "ReferenceType": "background",
            "ReferenceCitation": "Airaghi L, Ciceri L, Giannini S, Ferrero S, Meroni PL, Tedeschi A. Idiopathic pulmonary hemosiderosis in an adult. Favourable response to azathioprine. Monaldi Arch Chest Dis. 2001 Jun;56(3):211-3."
          },
          {
            "ReferencePMID": "12490803",
            "ReferenceType": "background",
            "ReferenceCitation": "Calabrese F, Giacometti C, Rea F, Loy M, Sartori F, Di Vittorio G, Abudureheman A, Thiene G, Valente M. Recurrence of idiopathic pulmonary hemosiderosis in a young adult patient after bilateral single-lung transplantation. Transplantation. 2002 Dec 15;74(11):1643-5."
          },
          {
            "ReferencePMID": "17609633",
            "ReferenceType": "background",
            "ReferenceCitation": "Chen RL, Chuang SS. Silent idiopathic pulmonary hemosiderosis with iron-deficiency anemia but normal serum ferritin. J Pediatr Hematol Oncol. 2007 Jul;29(7):509-11."
          },
          {
            "ReferencePMID": "15891110",
            "ReferenceType": "result",
            "ReferenceCitation": "Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 2005 Aug;33(2):145-52. Epub 2005 May 12."
          },
          {
            "ReferencePMID": "15615854",
            "ReferenceType": "result",
            "ReferenceCitation": "Wang G, Bunnell BA, Painter RG, Quiniones BC, Tom S, Lanson NA Jr, Spees JL, Bertucci D, Peister A, Weiss DJ, Valentine VG, Prockop DJ, Kolls JK. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):186-91. Epub 2004 Dec 22."
          },
          {
            "ReferencePMID": "19721001",
            "ReferenceType": "result",
            "ReferenceCitation": "Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16357-62. doi: 10.1073/pnas.0907996106. Epub 2009 Aug 31."
          },
          {
            "ReferencePMID": "21128750",
            "ReferenceType": "result",
            "ReferenceCitation": "Knight DA, Rossi FM, Hackett TL. Mesenchymal stem cells for repair of the airway epithelium in asthma. Expert Rev Respir Med. 2010 Dec;4(6):747-58. doi: 10.1586/ers.10.72. Review."
          },
          {
            "ReferencePMID": "21585237",
            "ReferenceType": "result",
            "ReferenceCitation": "Hoffman AM, Paxson JA, Mazan MR, Davis AM, Tyagi S, Murthy S, Ingenito EP. Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung. Stem Cells Dev. 2011 Oct;20(10):1779-92. doi: 10.1089/scd.2011.0105. Epub 2011 Jul 6."
          },
          {
            "ReferencePMID": "23154940",
            "ReferenceType": "result",
            "ReferenceCitation": "Liu AR, Liu L, Chen S, Yang Y, Zhao HJ, Liu L, Guo FM, Lu XM, Qiu HB. Activation of canonical wnt pathway promotes differentiation of mouse bone marrow-derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro. J Cell Physiol. 2013 Jun;228(6):1270-83. doi: 10.1002/jcp.24282."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000008171",
            "ConditionMeshTerm": "Lung Diseases"
          },
          {
            "ConditionMeshId": "D000006486",
            "ConditionMeshTerm": "Hemosiderosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000019190",
            "ConditionAncestorTerm": "Iron Overload"
          },
          {
            "ConditionAncestorId": "D000019189",
            "ConditionAncestorTerm": "Iron Metabolism Disorders"
          },
          {
            "ConditionAncestorId": "D000008659",
            "ConditionAncestorTerm": "Metabolic Diseases"
          },
          {
            "ConditionAncestorId": "D000012140",
            "ConditionAncestorTerm": "Respiratory Tract Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M8724",
            "ConditionBrowseLeafName": "Hemosiderosis",
            "ConditionBrowseLeafAsFound": "Hemosiderosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10320",
            "ConditionBrowseLeafName": "Lung Diseases",
            "ConditionBrowseLeafAsFound": "Pulmonary Hemosiderosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M20331",
            "ConditionBrowseLeafName": "Iron Overload",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10791",
            "ConditionBrowseLeafName": "Metabolic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M20330",
            "ConditionBrowseLeafName": "Iron Metabolism Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14129",
            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T2716",
            "ConditionBrowseLeafName": "Hemosiderosis",
            "ConditionBrowseLeafAsFound": "Hemosiderosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T3004",
            "ConditionBrowseLeafName": "Idiopathic Pulmonary Hemosiderosis",
            "ConditionBrowseLeafAsFound": "Idiopathic Pulmonary Hemosiderosis",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC08",
            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}